Gain Therapeutics, Inc. (GANX)
NASDAQ: GANX · Real-Time Price · USD
1.750
-0.070 (-3.85%)
At close: May 15, 2026, 4:00 PM EDT
1.780
+0.030 (1.71%)
After-hours: May 15, 2026, 7:56 PM EDT
Gain Therapeutics Market Cap
Gain Therapeutics has a market cap or net worth of $74.64 million as of May 15, 2026. Its market cap has increased by 26.20% in one year.
Market Cap
74.64M
Enterprise Value
60.06M
1-Year Change
26.20%
Ranking
Category
Stock Price
$1.75
Market Cap Chart
Since the IPO on March 18, 2021, Gain Therapeutics's market cap has decreased from $124.64M to $74.64M, a decrease of -40.11%. That is a compound annual growth rate of -9.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 73.90M | -24.36% |
| Dec 31, 2025 | 97.70M | 70.48% |
| Dec 31, 2024 | 57.31M | 8.14% |
| Dec 29, 2023 | 53.00M | 42.48% |
| Dec 30, 2022 | 37.19M | -42.36% |
| Dec 31, 2021 | 64.53M | -48.23% |
| Mar 18, 2021 | 124.64M | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Gossamer Bio | 79.80M |
| OS Therapies | 79.03M |
| MAIA Biotechnology | 76.45M |
| Acrivon Therapeutics | 75.76M |
| Rallybio | 75.64M |
| XBiotech | 75.00M |
| Cue Biopharma | 74.91M |
| PDS Biotechnology | 74.79M |